rucaparib
clovis oncology
['gu ', 'rucaparib', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
 highlights positive phase 3 data for #rucaparib as a new standard of care for #mcrpc patients who previously received an arpi but had not received chemo in the castration-resistant setting in our exclusive interview from #gu23: 
GU Oncology Now delivers the latest news in therapeutics, clinical trials, conference coverage, and important advancements in the genitourinary oncology field.